v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (10,307) $ (11,623)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 199 240
Stock-based compensation related to options granted to employees and directors 1,520 750
Change in operating lease liability, net 87 54
Decrease (increase) in prepaid expenses and other accounts receivable (83) 401
Increase (decrease) in trade payables 987 1,126
Increase in accrued expense 85  
Gain on change in fair value of warrants (Note 7) (179) (147)
Increase (decrease) in employees related liability and accrued expenses 716 106
Net cash used in operating activities (6,975) (9,093)
Cash flows from investing activities:    
Purchase of property and equipment   12
Total net cash provided by investing activities   12
Cash flows from financing activities:    
Proceeds from issuance of shares in at-the-market (ATM) offering (Note 8) 4,347 4,323
Proceeds from Issuance of shares for private placement (Note 8) [1]   3,644
Proceeds from short-term loans (Note 6) 582  
Proceeds from warrants issuance (Note 7) [1] 1,501  
Debt-for-Equity Swap 450  
Net cash provided by financing activities 6,880 7,967
Increase (decrease) in cash and cash equivalents (95) (1,114)
Cash, cash equivalents and restricted cash at the beginning of the period 371 1,485
Cash, cash equivalents and restricted cash at end of the period 276 $ 371
Non-Cash Activities:    
Reclassifying the warrants liabilities to equity (Note 8) $ 268  
[1] Presented after neutralizing costs of issuance.